Andrea Zaw, MD, Farrukh A Khan, MD, Prashanth Ramachandra, MD, Piotr Krecioch, MD, Leslie Anewenah, MD. Mercy Catholic Medical Center
Introduction: Benign gallbladder disease is commonly treated with Laparoscopic cholecystectomy (LC). Gallbladder cancer (GBC) is a rare malignancy characterized by high invasiveness and poor survival. In our institution, all gallbladder specimens are routinely sent to pathology, to rule out GBC. The purpose of our study was to assess the efficacy for routine histopathology of gallbladder specimens after cholecystectomy (CLY) for all gallbladder disease.
Methods and Procedures: After obtaining approval from our institutional review board, a retrospective review was conducted on all patients who underwent CLY from June of 2012 to May 2016 were included in the study. The data obtained include gender, age, American Society of Anesthesiologist score (ASA), body mass index (BMI), comorbidities, length of stay (LOS), radiological imaging and pathology results. Independent T and Chi-square tests were performed using IBM® SPSS® 24 software.
Results: There were 903 CLY performed at our institution, of which 842 (93%) were LC. Females composed of 675 (75%) patients and the median age was 48. 7(1%) gallbladder specimens were found to be cancerous. 896(99%) gallbladder specimens were benign. Majority 533(59%) were chronic cholecystitis, 238(27%) were acute cholecystitis and 22(2%) were gangrenous cholecystitis. 29(3%) were found to be acalculus cholecystitis and 5(1%) were cholelithiasis. 69(7%) were found to be adenomyositis, and other.
Conclusion: In our institution, less than 1%(7) of all gallbladder specimens were found to be cancerous. It would decrease cost and work load if gallbladder specimens are selectively sent to pathology.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 87767
Program Number: P095
Presentation Session: iPoster Session (Non CME)
Presentation Type: Poster